191 related articles for article (PubMed ID: 23270198)
1. Treatment of nodular basal cell carcinoma with cryotherapy and reduced protocol of imiquimod.
Moutran R; Maatouk I; Stephan F; Tomb R
Cutis; 2012 Nov; 90(5):256-7. PubMed ID: 23270198
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of clinical efficacy of imiquimod and cryotherapy for the treatment of basal cell carcinoma with incomplete response to imiquimod.
Messeguer F; Serra-Guillen C; Echeverria B; Requena C; Sanmartin O; Llombart B; Guillen C; Nagore E
J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):879-81. PubMed ID: 21752102
[TBL] [Abstract][Full Text] [Related]
3. Cryoimmunotherapy: superficial basal cell cancer and squamous cell carcinoma in situ treated with liquid nitrogen followed by imiquimod.
MacFarlane DF; El Tal AK
Arch Dermatol; 2011 Nov; 147(11):1326-7. PubMed ID: 22106125
[No Abstract] [Full Text] [Related]
4. Large facial basal cell carcinoma treated with multimodal combination therapy.
Rubenzik MK; Schwartz LR; Humphreys TR
Cutis; 2011 Oct; 88(4):182-4. PubMed ID: 22106726
[TBL] [Abstract][Full Text] [Related]
5. A 36-month clinical experience of the effectiveness of curettage and imiquimod 5% cream in the treatment of basal cell carcinoma.
Tillman DK; Carroll MT
J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s7-14. PubMed ID: 18277457
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report.
Rigel DS; Torres AM; Ely H
J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s15-6. PubMed ID: 18277458
[TBL] [Abstract][Full Text] [Related]
7. Immunocryosurgery for non-superficial basal cell carcinoma: a pro-spective, open-label phase III study for tumours ≤ 2 cm in diameter.
Gaitanis G; Bassukas ID
Acta Derm Venereol; 2014 Jan; 94(1):38-44. PubMed ID: 23722308
[TBL] [Abstract][Full Text] [Related]
8. An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma.
Wu JK; Oh C; Strutton G; Siller G
Australas J Dermatol; 2006 Feb; 47(1):46-8. PubMed ID: 16405483
[TBL] [Abstract][Full Text] [Related]
9. Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma.
Spencer JM
Dermatol Surg; 2006 Jan; 32(1):63-9. PubMed ID: 16393600
[TBL] [Abstract][Full Text] [Related]
10. Cryosurgery during Imiquimod (Immunocryosurgery) for Periocular Basal Cell Carcinomas: An Efficacious Minimally Invasive Treatment Alternative.
Gaitanis G; Kalogeropoulos CD; Bassukas ID
Dermatology; 2016; 232(1):17-21. PubMed ID: 26583773
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas.
Garcia-Martin E; Idoipe M; Gil LM; Pueyo V; Alfaro J; Pablo LE; Zubiri ML; Fernandez J
J Ocul Pharmacol Ther; 2010 Aug; 26(4):373-9. PubMed ID: 20698800
[TBL] [Abstract][Full Text] [Related]
12. Multiple superficial basal cell carcinomata--topical imiquimod versus curette and cryotherapy.
Dixon AJ
Aust Fam Physician; 2005; 34(1-2):49-52. PubMed ID: 15727358
[TBL] [Abstract][Full Text] [Related]
13. Scientific rationale: combining imiquimod and surgical treatments for basal cell carcinomas.
Berman B
J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s3-6. PubMed ID: 18277456
[TBL] [Abstract][Full Text] [Related]
14. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
Neville JA; Williford PM; Jorizzo JL
J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
[TBL] [Abstract][Full Text] [Related]
15. Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week period: a case series.
Ruiz-Villaverde R; Sánchez-Cano D; Burkhardt-Pérez P
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):828-31. PubMed ID: 19646136
[TBL] [Abstract][Full Text] [Related]
16. Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream.
Devirgiliis V; Panasiti V; Curzio M; Gobbi S; Rossi M; Roberti V; Calvieri S
Dermatol Online J; 2008 Feb; 14(2):25. PubMed ID: 18700128
[No Abstract] [Full Text] [Related]
17. Resolution of tinea pedis with imiquimod cream 5% in a patient with nodular basal cell carcinoma.
Stashower ME
Cutis; 2006 Jul; 78(1):66-9. PubMed ID: 16903324
[TBL] [Abstract][Full Text] [Related]
18. Treatment of various types of basal cell carcinoma with topical 5% imiquimod in the elderly who refused surgical intervention: a case series.
Kaçar SD; Özuğuz P; Erkan F; Karaca Ş
J Dermatolog Treat; 2015 Apr; 26(2):165-7. PubMed ID: 24731081
[TBL] [Abstract][Full Text] [Related]
19. Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream.
Requena C; Messeguer F; Llombart B; Serra-Guillén C; Guillén C
Int J Dermatol; 2012 Apr; 51(4):451-4. PubMed ID: 22435437
[TBL] [Abstract][Full Text] [Related]
20. Recurrent invasive basal cell carcinoma after radiation and imiquimod: a case report.
Wagamon K; Li LJ
Dermatol Surg; 2007 Jan; 33(1):117-9. PubMed ID: 17214692
[No Abstract] [Full Text] [Related]
[Next] [New Search]
